Corporate Research: Best Labs Combine Virtues Of Both Academia And Industry

Commercial productivity is the payoff when firms provide scientists with a comfortably collegiate professional environment Recognizing the successful tradition of the university science environment, industry research directors are carrying over the academic spirit in their efforts toward building harmonious and productive labs. Their aim is to preserve the pursuit of pure discovery and the free exchange of ideas, while at the same time moving assertively toward the achievement of commer

Written byFranklin Hoke
| 9 min read

Register for free to listen to this article
Listen with Speechify
0:00
9:00
Share

Commercial productivity is the payoff when firms provide scientists with a comfortably collegiate professional environment

In the biotechnology industry sector, this strategy--geared to, among other things, making their companies more inviting to talented young scientists--has paid off impressively for several firms.

"We've seen that we're competing with academic institutions for the kinds of scientists that we have," says Daniel Vapnek, senior

vice president for research at Amgen Inc., Thousand Oaks, Calif. "And it turns out that the kind of environment that we maintain is, in a lot of ways, like an academic environment."

Says Doug Williams, vice president and director of biological sciences for Immunex Corp., Seattle: "We have kept our good young investigators happy by enabling them to publish their findings and go to scientific meetings and be recognized by the scientific community at large, as opposed to just being recognized within the organization.

"That, I think, has helped ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies